CYP2C9 and Hepatic failure: Our findings are contradictory to our hypothesis that liver failure would reduce the predominant metabolism of voriconazole by the cytochrome P450 enzymes (CYP), mainly CYP2C19 as well as CYP3A4 and CYP2C9 [26].